Reports

Industry Research Reports

Global Bionic Exoskeletons Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Bionic Exoskeletons Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published Date: 2025-10-30

Pages: 174 Pages

Report ld: 5313034

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Bionic Exoskeletons market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

From a downstream perspective, Medical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Bionic Exoskeletons leading manufacturers including Ekso Bionics, Ottobock Inc, DJO Global Inc., Ossur Corporate, Rex Bionics Ltd., Alter G, ReWalk Robotics, Axosuits, EduExo, Festo, etc., dominate supply; the top five capture approximately % of global revenue, with Ekso Bionics leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Bionic Exoskeletons market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Ekso Bionics
  • Ottobock Inc
  • DJO Global Inc.
  • Ossur Corporate
  • Rex Bionics Ltd.
  • Alter G
  • ReWalk Robotics
  • Axosuits
  • EduExo
  • Festo
  • Lockheed Martin
  • BAE Systems
  • Raytheon
  • General Dynamics
  • Honeywell
  • Bionic Power

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Active Exoskeletons
  • Passive Exoskeletons

Segment by Application

  • Medical
  • Military

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Bionic Exoskeletons study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

marn_i1

Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

marn_i1

Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

marn_i1

Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

marn_i1

Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.

marn_i1

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Bionic Exoskeletons: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Bionic Exoskeletons Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Active Exoskeletons

1.2.3 Passive Exoskeletons

1.3 Market Segmentation by Application

1.3.1 Global Bionic Exoskeletons Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Medical

1.3.3 Military

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Bionic Exoskeletons Revenue Estimates and Forecasts 2020-2031

2.2 Global Bionic Exoskeletons Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Bionic Exoskeletons Sales Estimates and Forecasts 2020-2031

2.4 Global Bionic Exoskeletons Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

muLu

3 Competition by Manufacturers

3.1 Global Bionic Exoskeletons Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Bionic Exoskeletons Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Active Exoskeletons Market Size by Manufacturers

3.5.2 Passive Exoskeletons Market Size by Manufacturers

3.6 Global Bionic Exoskeletons Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

4 Global Product Segmentation Analysis

4.1 Global Bionic Exoskeletons Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Bionic Exoskeletons Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

muLu

5 Global Downstream Application Analysis

5.1 Global Bionic Exoskeletons Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Bionic Exoskeletons Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

muLu

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Bionic Exoskeletons Sales and Revenue by Type (2020-2031)

6.4 North America Bionic Exoskeletons Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Bionic Exoskeletons Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

muLu

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Bionic Exoskeletons Sales and Revenue by Type (2020-2031)

7.4 Europe Bionic Exoskeletons Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Bionic Exoskeletons Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

muLu

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Bionic Exoskeletons Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Bionic Exoskeletons Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Bionic Exoskeletons Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

muLu

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Bionic Exoskeletons Sales and Revenue by Type (2020-2031)

9.4 Central and South America Bionic Exoskeletons Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Bionic Exoskeletons Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

muLu

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Bionic Exoskeletons Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Bionic Exoskeletons Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Bionic Exoskeletons Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

muLu

11 Corporate Profile

11.1 Ekso Bionics

11.1.1 Ekso Bionics Corporation Information

11.1.2 Ekso Bionics Business Overview

11.1.3 Ekso Bionics Bionic Exoskeletons Product Models, Descriptions and Specifications

11.1.4 Ekso Bionics Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Ekso Bionics Bionic Exoskeletons Sales by Product in 2024

11.1.6 Ekso Bionics Bionic Exoskeletons Sales by Application in 2024

11.1.7 Ekso Bionics Bionic Exoskeletons Sales by Geographic Area in 2024

11.1.8 Ekso Bionics Bionic Exoskeletons SWOT Analysis

11.1.9 Ekso Bionics Recent Developments

11.2 Ottobock Inc

11.2.1 Ottobock Inc Corporation Information

11.2.2 Ottobock Inc Business Overview

11.2.3 Ottobock Inc Bionic Exoskeletons Product Models, Descriptions and Specifications

11.2.4 Ottobock Inc Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Ottobock Inc Bionic Exoskeletons Sales by Product in 2024

11.2.6 Ottobock Inc Bionic Exoskeletons Sales by Application in 2024

11.2.7 Ottobock Inc Bionic Exoskeletons Sales by Geographic Area in 2024

11.2.8 Ottobock Inc Bionic Exoskeletons SWOT Analysis

11.2.9 Ottobock Inc Recent Developments

11.3 DJO Global Inc.

11.3.1 DJO Global Inc. Corporation Information

11.3.2 DJO Global Inc. Business Overview

11.3.3 DJO Global Inc. Bionic Exoskeletons Product Models, Descriptions and Specifications

11.3.4 DJO Global Inc. Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 DJO Global Inc. Bionic Exoskeletons Sales by Product in 2024

11.3.6 DJO Global Inc. Bionic Exoskeletons Sales by Application in 2024

11.3.7 DJO Global Inc. Bionic Exoskeletons Sales by Geographic Area in 2024

11.3.8 DJO Global Inc. Bionic Exoskeletons SWOT Analysis

11.3.9 DJO Global Inc. Recent Developments

11.4 Ossur Corporate

11.4.1 Ossur Corporate Corporation Information

11.4.2 Ossur Corporate Business Overview

11.4.3 Ossur Corporate Bionic Exoskeletons Product Models, Descriptions and Specifications

11.4.4 Ossur Corporate Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Ossur Corporate Bionic Exoskeletons Sales by Product in 2024

11.4.6 Ossur Corporate Bionic Exoskeletons Sales by Application in 2024

11.4.7 Ossur Corporate Bionic Exoskeletons Sales by Geographic Area in 2024

11.4.8 Ossur Corporate Bionic Exoskeletons SWOT Analysis

11.4.9 Ossur Corporate Recent Developments

11.5 Rex Bionics Ltd.

11.5.1 Rex Bionics Ltd. Corporation Information

11.5.2 Rex Bionics Ltd. Business Overview

11.5.3 Rex Bionics Ltd. Bionic Exoskeletons Product Models, Descriptions and Specifications

11.5.4 Rex Bionics Ltd. Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Rex Bionics Ltd. Bionic Exoskeletons Sales by Product in 2024

11.5.6 Rex Bionics Ltd. Bionic Exoskeletons Sales by Application in 2024

11.5.7 Rex Bionics Ltd. Bionic Exoskeletons Sales by Geographic Area in 2024

11.5.8 Rex Bionics Ltd. Bionic Exoskeletons SWOT Analysis

11.5.9 Rex Bionics Ltd. Recent Developments

11.6 Alter G

11.6.1 Alter G Corporation Information

11.6.2 Alter G Business Overview

11.6.3 Alter G Bionic Exoskeletons Product Models, Descriptions and Specifications

11.6.4 Alter G Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Alter G Recent Developments

11.7 ReWalk Robotics

11.7.1 ReWalk Robotics Corporation Information

11.7.2 ReWalk Robotics Business Overview

11.7.3 ReWalk Robotics Bionic Exoskeletons Product Models, Descriptions and Specifications

11.7.4 ReWalk Robotics Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 ReWalk Robotics Recent Developments

11.8 Axosuits

11.8.1 Axosuits Corporation Information

11.8.2 Axosuits Business Overview

11.8.3 Axosuits Bionic Exoskeletons Product Models, Descriptions and Specifications

11.8.4 Axosuits Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Axosuits Recent Developments

11.9 EduExo

11.9.1 EduExo Corporation Information

11.9.2 EduExo Business Overview

11.9.3 EduExo Bionic Exoskeletons Product Models, Descriptions and Specifications

11.9.4 EduExo Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 EduExo Recent Developments

11.10 Festo

11.10.1 Festo Corporation Information

11.10.2 Festo Business Overview

11.10.3 Festo Bionic Exoskeletons Product Models, Descriptions and Specifications

11.10.4 Festo Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Festo Recent Developments

11.11 Lockheed Martin

11.11.1 Lockheed Martin Corporation Information

11.11.2 Lockheed Martin Business Overview

11.11.3 Lockheed Martin Bionic Exoskeletons Product Models, Descriptions and Specifications

11.11.4 Lockheed Martin Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Lockheed Martin Recent Developments

11.12 BAE Systems

11.12.1 BAE Systems Corporation Information

11.12.2 BAE Systems Business Overview

11.12.3 BAE Systems Bionic Exoskeletons Product Models, Descriptions and Specifications

11.12.4 BAE Systems Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 BAE Systems Recent Developments

11.13 Raytheon

11.13.1 Raytheon Corporation Information

11.13.2 Raytheon Business Overview

11.13.3 Raytheon Bionic Exoskeletons Product Models, Descriptions and Specifications

11.13.4 Raytheon Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 Raytheon Recent Developments

11.14 General Dynamics

11.14.1 General Dynamics Corporation Information

11.14.2 General Dynamics Business Overview

11.14.3 General Dynamics Bionic Exoskeletons Product Models, Descriptions and Specifications

11.14.4 General Dynamics Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 General Dynamics Recent Developments

11.15 Honeywell

11.15.1 Honeywell Corporation Information

11.15.2 Honeywell Business Overview

11.15.3 Honeywell Bionic Exoskeletons Product Models, Descriptions and Specifications

11.15.4 Honeywell Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.15.5 Honeywell Recent Developments

11.16 Bionic Power

11.16.1 Bionic Power Corporation Information

11.16.2 Bionic Power Business Overview

11.16.3 Bionic Power Bionic Exoskeletons Product Models, Descriptions and Specifications

11.16.4 Bionic Power Bionic Exoskeletons Sales, Price, Revenue and Gross Margin (2020-2025)

11.16.5 Bionic Power Recent Developments

muLu

12 Value Chain and Supply-Chain Analysis

12.1 Bionic Exoskeletons Industry Chain

12.2 Bionic Exoskeletons Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Bionic Exoskeletons Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Bionic Exoskeletons Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

muLu

13 Bionic Exoskeletons Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

muLu

14 Key Findings in the Global Bionic Exoskeletons Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Bionic Exoskeletons Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bionic Exoskeletons Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bionic Exoskeletons Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bionic Exoskeletons Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bionic Exoskeletons Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Bionic Exoskeletons Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Bionic Exoskeletons Sales by Region (2020-2025) & (K Units)
Table 8. Global Bionic Exoskeletons Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Bionic Exoskeletons Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Bionic Exoskeletons Sales Share by Manufacturers (2020-2025)
Table 12. Global Bionic Exoskeletons Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Bionic Exoskeletons Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Bionic Exoskeletons by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bionic Exoskeletons as of 2024)
Table 16. Global Bionic Exoskeletons Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Bionic Exoskeletons Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Unit)
Table 18. Key Manufacturers Bionic Exoskeletons Manufacturing Base and Headquarters
Table 19. Global Bionic Exoskeletons Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Bionic Exoskeletons Sales by Type (2020-2025) & (K Units)
Table 23. Global Bionic Exoskeletons Sales by Type (2026-2031) & (K Units)
Table 24. Global Bionic Exoskeletons Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Bionic Exoskeletons Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Bionic Exoskeletons ASP by Type (2020-2031) & (USD/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Bionic Exoskeletons Sales by Application (2020-2025) & (K Units)
Table 29. Global Bionic Exoskeletons Sales by Application (2026-2031) & (K Units)
Table 30. Bionic Exoskeletons High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Bionic Exoskeletons Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Bionic Exoskeletons Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Bionic Exoskeletons ASP by Application (2020-2031) & (USD/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Bionic Exoskeletons Growth Accelerators and Market Barriers
Table 37. North America Bionic Exoskeletons Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Bionic Exoskeletons Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Bionic Exoskeletons Growth Accelerators and Market Barriers
Table 40. Europe Bionic Exoskeletons Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Bionic Exoskeletons Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Bionic Exoskeletons Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Bionic Exoskeletons Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Bionic Exoskeletons Growth Accelerators and Market Barriers
Table 45. Southeast Asia Bionic Exoskeletons Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Bionic Exoskeletons Investment Opportunities and Key Challenges
Table 47. Central and South America Bionic Exoskeletons Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Bionic Exoskeletons Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Bionic Exoskeletons Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Ekso Bionics Corporation Information
Table 51. Ekso Bionics Description and Major Businesses
Table 52. Ekso Bionics Product Models, Descriptions and Specifications
Table 53. Ekso Bionics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 54. Ekso Bionics Sales Value Proportion by Product in 2024
Table 55. Ekso Bionics Sales Value Proportion by Application in 2024
Table 56. Ekso Bionics Sales Value Proportion by Geographic Area in 2024
Table 57. Ekso Bionics Bionic Exoskeletons SWOT Analysis
Table 58. Ekso Bionics Recent Developments
Table 59. Ottobock Inc Corporation Information
Table 60. Ottobock Inc Description and Major Businesses
Table 61. Ottobock Inc Product Models, Descriptions and Specifications
Table 62. Ottobock Inc Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Ottobock Inc Sales Value Proportion by Product in 2024
Table 64. Ottobock Inc Sales Value Proportion by Application in 2024
Table 65. Ottobock Inc Sales Value Proportion by Geographic Area in 2024
Table 66. Ottobock Inc Bionic Exoskeletons SWOT Analysis
Table 67. Ottobock Inc Recent Developments
Table 68. DJO Global Inc. Corporation Information
Table 69. DJO Global Inc. Description and Major Businesses
Table 70. DJO Global Inc. Product Models, Descriptions and Specifications
Table 71. DJO Global Inc. Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. DJO Global Inc. Sales Value Proportion by Product in 2024
Table 73. DJO Global Inc. Sales Value Proportion by Application in 2024
Table 74. DJO Global Inc. Sales Value Proportion by Geographic Area in 2024
Table 75. DJO Global Inc. Bionic Exoskeletons SWOT Analysis
Table 76. DJO Global Inc. Recent Developments
Table 77. Ossur Corporate Corporation Information
Table 78. Ossur Corporate Description and Major Businesses
Table 79. Ossur Corporate Product Models, Descriptions and Specifications
Table 80. Ossur Corporate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Ossur Corporate Sales Value Proportion by Product in 2024
Table 82. Ossur Corporate Sales Value Proportion by Application in 2024
Table 83. Ossur Corporate Sales Value Proportion by Geographic Area in 2024
Table 84. Ossur Corporate Bionic Exoskeletons SWOT Analysis
Table 85. Ossur Corporate Recent Developments
Table 86. Rex Bionics Ltd. Corporation Information
Table 87. Rex Bionics Ltd. Description and Major Businesses
Table 88. Rex Bionics Ltd. Product Models, Descriptions and Specifications
Table 89. Rex Bionics Ltd. Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Rex Bionics Ltd. Sales Value Proportion by Product in 2024
Table 91. Rex Bionics Ltd. Sales Value Proportion by Application in 2024
Table 92. Rex Bionics Ltd. Sales Value Proportion by Geographic Area in 2024
Table 93. Rex Bionics Ltd. Bionic Exoskeletons SWOT Analysis
Table 94. Rex Bionics Ltd. Recent Developments
Table 95. Alter G Corporation Information
Table 96. Alter G Description and Major Businesses
Table 97. Alter G Product Models, Descriptions and Specifications
Table 98. Alter G Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Alter G Recent Developments
Table 100. ReWalk Robotics Corporation Information
Table 101. ReWalk Robotics Description and Major Businesses
Table 102. ReWalk Robotics Product Models, Descriptions and Specifications
Table 103. ReWalk Robotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. ReWalk Robotics Recent Developments
Table 105. Axosuits Corporation Information
Table 106. Axosuits Description and Major Businesses
Table 107. Axosuits Product Models, Descriptions and Specifications
Table 108. Axosuits Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Axosuits Recent Developments
Table 110. EduExo Corporation Information
Table 111. EduExo Description and Major Businesses
Table 112. EduExo Product Models, Descriptions and Specifications
Table 113. EduExo Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. EduExo Recent Developments
Table 115. Festo Corporation Information
Table 116. Festo Description and Major Businesses
Table 117. Festo Product Models, Descriptions and Specifications
Table 118. Festo Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 119. Festo Recent Developments
Table 120. Lockheed Martin Corporation Information
Table 121. Lockheed Martin Description and Major Businesses
Table 122. Lockheed Martin Product Models, Descriptions and Specifications
Table 123. Lockheed Martin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 124. Lockheed Martin Recent Developments
Table 125. BAE Systems Corporation Information
Table 126. BAE Systems Description and Major Businesses
Table 127. BAE Systems Product Models, Descriptions and Specifications
Table 128. BAE Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 129. BAE Systems Recent Developments
Table 130. Raytheon Corporation Information
Table 131. Raytheon Description and Major Businesses
Table 132. Raytheon Product Models, Descriptions and Specifications
Table 133. Raytheon Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 134. Raytheon Recent Developments
Table 135. General Dynamics Corporation Information
Table 136. General Dynamics Description and Major Businesses
Table 137. General Dynamics Product Models, Descriptions and Specifications
Table 138. General Dynamics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 139. General Dynamics Recent Developments
Table 140. Honeywell Corporation Information
Table 141. Honeywell Description and Major Businesses
Table 142. Honeywell Product Models, Descriptions and Specifications
Table 143. Honeywell Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 144. Honeywell Recent Developments
Table 145. Bionic Power Corporation Information
Table 146. Bionic Power Description and Major Businesses
Table 147. Bionic Power Product Models, Descriptions and Specifications
Table 148. Bionic Power Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 149. Bionic Power Recent Developments
Table 150. Key Raw Materials Distribution
Table 151. Raw Materials Key Suppliers
Table 152. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 153. Milestones in Production Technology Evolution
Table 154. Distributors List
Table 155. Market Trends and Market Evolution
Table 156. Market Drivers and Opportunities
Table 157. Market Challenges, Risks, and Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Bionic Exoskeletons Product Picture
Figure 2. Global Bionic Exoskeletons Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Active Exoskeletons Product Picture
Figure 4. Passive Exoskeletons Product Picture
Figure 5. Global Bionic Exoskeletons Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Medical
Figure 7. Military
Figure 8. Bionic Exoskeletons Report Years Considered
Figure 9. Global Bionic Exoskeletons Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 11. Global Bionic Exoskeletons Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Bionic Exoskeletons Revenue Market Share by Region (2020-2031)
Figure 13. Global Bionic Exoskeletons Sales (2020-2031) & (K Units)
Figure 14. Global Bionic Exoskeletons Sales (CAGR) by Region (2020-2031) (K Units)
Figure 15. Global Bionic Exoskeletons Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Bionic Exoskeletons Sales Volume Market Share in 2024
Figure 17. Global Bionic Exoskeletons Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Active Exoskeletons Revenue Market Share by Manufacturer in 2024
Figure 20. Passive Exoskeletons Revenue Market Share by Manufacturer in 2024
Figure 21. Global Bionic Exoskeletons Sales Market Share by Type (2020-2031)
Figure 22. Global Bionic Exoskeletons Revenue Market Share by Type (2020-2031)
Figure 23. Global Bionic Exoskeletons Sales Market Share by Application (2020-2031)
Figure 24. Global Bionic Exoskeletons Revenue Market Share by Application (2020-2031)
Figure 25. North America Bionic Exoskeletons Sales YoY (2020-2031) & (K Units)
Figure 26. North America Bionic Exoskeletons Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Bionic Exoskeletons Sales Revenue (US$ Million) in 2024
Figure 28. North America Bionic Exoskeletons Sales Volume (K Units) by Type (2020- 2031)
Figure 29. North America Bionic Exoskeletons Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Bionic Exoskeletons Sales Volume (K Units) by Application (2020-2031)
Figure 31. North America Bionic Exoskeletons Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Bionic Exoskeletons Sales YoY (2020-2031) & (K Units)
Figure 36. Europe Bionic Exoskeletons Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Bionic Exoskeletons Sales Revenue (US$ Million) in 2024
Figure 38. Europe Bionic Exoskeletons Sales Volume (K Units) by Type (2020-2031)
Figure 39. Europe Bionic Exoskeletons Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Bionic Exoskeletons Sales Volume (K Units) by Application (2020-2031)
Figure 41. Europe Bionic Exoskeletons Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 43. France Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Bionic Exoskeletons Sales YoY (2020-2031) & (K Units)
Figure 48. Asia-Pacific Bionic Exoskeletons Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Bionic Exoskeletons Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Bionic Exoskeletons Sales Volume (K Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Bionic Exoskeletons Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Bionic Exoskeletons Sales Volume (K Units) by Application (2020-2031)
Figure 53. Asia-Pacific Bionic Exoskeletons Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 58. India Bionic Exoskeletons Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Bionic Exoskeletons Sales YoY (2020-2031) & (K Units)
Figure 60. Central and South America Bionic Exoskeletons Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Bionic Exoskeletons Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Bionic Exoskeletons Sales Volume (K Units) by Type (2021-2031)
Figure 63. Central and South America Bionic Exoskeletons Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Bionic Exoskeletons Sales Volume (K Units) by Application (2020-2031)
Figure 65. Central and South America Bionic Exoskeletons Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Bionic Exoskeletons Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Bionic Exoskeletons Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Bionic Exoskeletons Sales YoY (2020-2031) & (K Units)
Figure 69. Middle East and Africa Bionic Exoskeletons Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Bionic Exoskeletons Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Bionic Exoskeletons Sales Volume (K Units) by Type (2021-2031)
Figure 72. South America Bionic Exoskeletons Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Bionic Exoskeletons Sales Volume (K Units) by Application (2020-2031)
Figure 74. Middle East and Africa Bionic Exoskeletons Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Bionic Exoskeletons Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Bionic Exoskeletons Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Bionic Exoskeletons Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Bionic Exoskeletons Revenue (2020-2025) & (US$ Million)
Figure 79. Bionic Exoskeletons Industry Chain Mapping
Figure 80. Regional Bionic Exoskeletons Manufacturing Base Distribution (%)
Figure 81. Global Bionic Exoskeletons Production Market Share by Region (2020-2031)
Figure 82. Bionic Exoskeletons Production Process
Figure 83. Regional Bionic Exoskeletons Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Bionic Exoskeletons market?zhanKai
The top companies in the global Bionic Exoskeletons market are Ekso Bionics、Ottobock Inc、DJO Global Inc..
den_biaoTiZhungShi

Related Reports

Global Bionic Exoskeletons Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published Date: 2025-10-30

Pages: 174 Pages

Report ld: 5313034

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now